Dr. Amrita Sahu is an Assistant Professor in the Department of Physical Medicine and Rehabilitation at the University of Pittsburgh School of Medicine. Dr. Sahu is also the Scientific Program Coordinator of the Alliance of Regenerative Rehabilitation Research and Training. Dr. Sahu received her B.Tech in Biomedical Engineering from Manipal University, India. She then graduated with MS in Biomedical Engineering from Carnegie Mellon University, followed by a PhD in Environmental and Occupational Health from the Graduate School of Public Health at the University of Pittsburgh. As a doctoral student, her overarching goal was to identify Klotho (an anti-aging protein) as a potential therapeutic target for enhancing the skeletal muscle healing capacity of the geriatric population by enhancing skeletal muscle mitochondrial health. Dr. Sahu joined the Department of Physical Medicine and Rehabilitation at University of Pittsburgh as a Postdoctoral Associate in 2020. She investigated the role of exercise on the molecular profile of circulating extracellular vesicles as well as the mechanisms underlying an age-related decrease in skeletal muscle regenerative capacity. As an Assistant Professor, Dr. Sahu’s long-term goal is to develop targeted rehabilitation strategies for enhancing skeletal muscle and cognitive functional capacity in a geriatric population. Recently, her research interests have taken her to explore the unexplored quantum phenomena in human body that may open several avenues into developing bio-therapeutics and precise rehabilitation strategies. Dr. Sahu’s research interests lie in aging, skeletal muscle physiology, skeletal muscle-brain axis, circulating biomarkers, regenerative medicine, quantum biology, and rehabilitation sciences.
Dr. Amrita Sahu
May 16, 2022
Recent Posts
- Ketogenic Diet Enhances CAR-T Cancer Therapy
- Socioeconomic Barriers Limit Access to Lifesaving Stem Cell Transplants in AML
- Newly discovered mechanism in the cell’s energy factory can lead to new treatment of muscle disorders
- New drug tested to reduce side effect of ‘half-matched’ stem cell transplants
- Gene and Cell Therapies Take Aim at Parkinson’s Disease
- Health Net grant for UC Davis Stem Cell Program to improve access to CAR T-cell therapy